ReviewFrontiers in immunology2026

Cyclin-dependent kinase 4 and 6 inhibitors and the breast cancer immune ecosystem: immune remodeling, resistance, and therapeutic reprogramming.

Yuhan Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.